English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/47791
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Phosphodiesterase inhibitor-dependent inverse agonism of agouti-related protein on melanocortin 4 receptor in sea bass (Dicentrarchus labrax)

Other TitlesAGRP inverse agonism
AuthorsSánchez, Elisa ; Rubio, V. C.; Thompson, Darren; Metz, Juriaan R.; Flik, Gert; Millhauser, Glenn L.; Cerdá-Reverter, José Miguel
KeywordsMelanocyte-stimulating hormone (MSH)
Proopiomelanocortin (POMC)
MC4R
Constitutive Activity
IBMX
Obesity
Issue DateMay-2009
PublisherAmerican Physiological Society
CitationAmerican journal of physiology. Regulatory, integrative and comparative physiology 296(5): R1293-R1306 (2009)
AbstractThe melanocortin 4 receptor (MC4R) is a G-protein coupled receptor mainly expressed in the central nervous system of vertebrates. Activation of the MC4R leads to a decrease in food intake, while inactivating mutations are a genetic cause of obesity. The binding of agoutirelated protein (AGRP) reduces agonist-stimulated cAMP production (competitive antagonist) but also the basal activity of the receptor, as an inverse agonist. Transgenic zebrafish overexpresing AGRP display increased food intake and linear growth, indicative of a physiological role for the melanocortin system in the control of the energy balance in fish. We report on the cloning, pharmacological characterization, tissue distribution and detailed brain mapping of a sea bass (Dicentrarchus labrax) MC4R orthologue. Sea bass MC4R is profusely expressed within food-intake controlling pathways of the fish brain. However, the activity of the melanocortin system during progressive fasting does not depend on the hypothalamic/pituitary proopiomelanocortin (POMC) and MC4R expression, which suggests that sea bass MC4R is constitutively activated and regulated by AGRP binding. We demonstrate that AGRP acts as competitive antagonist and reduces MTII-induced cAMP production. AGRP also decreases the basal activity of the receptor as an inverse agonist. This observation suggests that MC4R is constitutively active and supports the evolutionary conservation of the AGRP/MC4R interactions. The inverse agonism, but not the competitive antagonism, depends on the presence of a phosphodiesterase inhibitor (IBMX). This suggests that inverse agonism and competitive antagonism operate through different intracellular signalling pathways, a view that open up new targets for the treatment of melanocortininduced metabolic syndrome.
Description54 p., 9 figures, 1 table and bibliography
Publisher version (URL)http://dx.doi.org/10.1152/ajpregu.90948.2008
URIhttp://hdl.handle.net/10261/47791
DOI10.1152/ajpregu.90948.2008
ISSN0363-6119
E-ISSN1522-1490
Appears in Collections:(IATS) Artículos
Files in This Item:
File Description SizeFormat 
Phosphodiesterase inhibitor-dependent.pdf800 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.